University of California San Francisco
Displaying 121 - 150 of 16991
-
-
Big Tobacco Uses Cigarette Playbook To Help Sell Ultra-Processed Foods, Journal Reveals
-
A Stroke Left 17-Year-Old Andrew Hunched on the Floor in Pain
Two decades ago, children with stroke were falling into this gap between stroke providers who didn’t treat children and child neurologists who were uncomfortable with stroke. Today, UCSF is at the forefront of pediatric stroke care and research.
-
How Big Tobacco Helped Shape the Design of Ultra-Processed Foods
A study looked at how ultraprocessed foods (UPFs), like Lunchables, are designed—and why they may lead to overeating and weight gain. Using internal company documents, the study showed that Lunchables were influenced by strategies from the tobacco industry, specifically Philip Morris, which once owned Kraft.
-
Environment June 2, 2026 Nike’s Recycled World Cup Uniforms Sound Groovy, But the Reality Is Complicated
-
How New AI Cuts Breast Cancer Screening Time for High-Risk Women
Using AI on mammograms can identify patients at highest risk for breast cancer and get them same-day follow up care, eliminating stressful waiting times.
-
UCSF Commencement 2026
What a year to celebrate! The members of the class of 2023 have shown their resilience and dedication to advance health research and patient care in ways we never imagined a few years ago. Truly impressive. We celebrate you all!
-
Doctor Provides Insight on UCSF Alzheimer’s Blood Test Study
-
New Research Helps Explain How Human Brains Are Able Decode Speech So Quickly
-
Do Red Light Therapy Masks Actually Work? Here’s What Dermatologists Say
-
Global Rules Could Cut Costs and Speed Access to GLP-1 Drugs
UCSF research shows that international rules for biosimilars, mimics of biologic drugs like Ozempic and insulin, need to improve and match each another to encourage biosimilar development, testing, and approval. This would dramatically improve drug affordability just like generics has done.
-
2026 Chancellor Distinguished Service Awards
UCSF salutes the individuals whose exemplary service reflects the university’s sustained commitment to serving our people and the broader community.
-
Can an Alzheimer’s Blood Test Detect Early, Subtle Cognitive Decline?
About 6% of asymptomatic adults have a biomarker for Alzheimer's disease and are already showing very subtle signs of the disease that would not come to light in a standard cognitive test.
-
Innovative Diabetes Researcher Joins National Academy of Sciences
Mark Anderson, MD, PhD, a pioneer in diabetes research and professor of medicine at UCSF, has been elected to the National Academy of Sciences — one of the highest honors in American science.
-
Improving Prediction of Alzheimer’s Disease with AI
A team at UCSF developed a multitask deep learning framework that can effectively predict Alzheimer’s disease diagnosis, cognitive scores, and future cognitive decline using only baseline MRI and demographics.
-
Health Coaches Improve Outcomes for Patients with Asthma and COPD
Pairing vulnerable, low-income patients with asthma coaches can improve outcomes and may also reduce costs associated with avoidable health care use.
-
How to Overcome Global Price Barriers for New Alzheimer’s Drugs
In the last few years, progress has been made in the fight against Alzheimer’s disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These anti-Aβ therapies, like lecanumab
-
The Liver’s Immune Cells Might Be the Key to Curing Hepatitis B
Jody Baron and Gabi Fragiadakis discover why some people with chronic Hepatitis B are cured after they're taken off of antiviral drugs, despite falling severely ill when the drug regiment stops.
-
Why Measles Is Spreading Again and Who Faces the Highest Risk
UCSF expert Charles Chiu discusses rising measles cases, extreme contagiousness, and why 95% vaccination rates are vital for community safety.
-
This Anti-CRISPR Stops the Protein Assembly Line in Bacteria
Joe Bondy-Denomy solves a CRISPR caper: this is how a viral protein stows itself on protein factories in bacteria, and destroys a CRISPR protein, designed to kill viruses, while it's being made.
-
Are Your Meds and DNA a Bad Match? This Test Alerts Clinicians
UCSF’s pharmacogenetics program uses DNA testing to personalize prescriptions, reducing side effects and ensuring the right drug and dose for every patient.
-
2026 Alumni Awards Recognize Visionary Leaders Shaping the Future of Health
The Alumni Association of UCSF (AAUCSF) announced the recipients of the 2026 UCSF Alumni Achievement Awards, recognizing outstanding alumni from UCSF’s schools.
-
UCSF Receives Major Gift to Advance Research and Modernization
UCSF has received a $100 million commitment from longtime supporters Kathy Chiao and Kenneth Hao to address its most urgent capital needs and accelerate innovation to advance human health.
-
In the Face of Cuts, W.M. Keck Foundation Supports Vital Research
Six pairs of UC San Francisco faculty members and their PhD students have been awarded funding through the W. M. Keck Foundation’s inaugural Scholar-Fellow Bridge Initiative, a program designed to
-
How UCSF Teams with Oakland Mayor, Faith Leaders to Stop Violence
Attendees at a community breakfast for Oakland faith leaders hosted by Nicholas Holmes and Oakland Mayor Lee discussed youth violence prevention initiatives and other community topics.
-
UCSF Community Honors Life of Doris Fisher (1931 – 2026)
Doris Fisher, a visionary philanthropist and longtime champion of UCSF who passed away in May 2026, devoted more than four decades to advancing the university’s mission. She served as a Lifetime Director on the UCSF Foundation Board and played a key role in building the UCSF Foundation.
-
UC Regents Approve New UCSF Bakar Ear & Hearing Institute
The University of California Board of Regents approved plans for the UCSF Bakar Ear & Hearing Institute, a new, state-of-the-art ear facility at UCSF’s Mission Bay campus, taking the first step to creating one of the world’s leading centers for advancing research and care for hearing and balance disorders.
-
Can Blockbuster GLP-1 Weight-Loss Drugs Also Protect Brain Health?
Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular conditions. New evidence shows that the drugs may also protect against neurological diseases, like dementia, Parkinson's, and substance use disorder.
-
One Dose of Psilocybin Changes the Human Brain
A large team of scientists, found that a single dose of psilocybin created positive changes in the brain and well-being, one hour and one month after administration.
-
UCSF Health Named to Becker’s Top Workplaces in Health Care List
UCSF Health was named a top place to work by Becker's Healthcare.
